Showing 281 - 300 results of 342 for search '"Mycobacterium tuberculosis"', query time: 0.05s Refine Results
  1. 281

    Unveiling Genital Tuberculosis: India’s hidden Infertility Epidemic by Yashvanthan VR, Angeline Grace G, Sujitha P, Ilam Ilaval T, Hariharan S

    Published 2025-02-01
    “…Hematogenous spread of Mycobacterium tuberculosis leads to chronic inflammation, fibrosis, and scarring of reproductive organs, resulting in irreversible damage. …”
    Get full text
    Article
  2. 282

    Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis by Peijun Tang, Xingnian Chen, Junchi Xu, Yunlong Hu, Zhijian Ye, Xiafang Wang, Yumei Xiao, Xinghua Shen, Jianping Zhang, Yanjun Feng, Cuilin Shi, Xin Yu, Lixian Yi, Xinchun Chen, Binfeng Lu, Ping Xu, Zhongwen Sun, Meiying Wu

    Published 2022-01-01
    “…T cell-mediated immunity plays a critical role in controlling Mycobacterium tuberculosis (Mtb) infection, and therefore, enhancing Mtb-specific T cell immune responses represents a promising therapeutic strategy against TB. …”
    Get full text
    Article
  3. 283

    Two-centers machine learning analysis for predicting acid-fast bacilli results in tuberculosis sputum tests by Jichong Zhu, Yong Zhao, Chengqian Huang, Chenxing Zhou, Shaofeng Wu, Tianyou Chen, Xinli Zhan

    Published 2025-02-01
    “…Background: Tuberculosis (TB) is a chronic respiratory infectious disease caused by Mycobacterium tuberculosis, typically diagnosed through sputum smear microscopy for acid-fast bacilli (AFB) to assess the infectivity of TB. …”
    Get full text
    Article
  4. 284

    Profil Kasus Tuberkulosis Paru di Instalasi Rawat Inap Paru RSUP Dr. M. Djamil Padang Periode 1 Januari 2010 - 31 Desember 2011 by Muhammad Gamal Eddin, Oea Khairsyaf, Elly Usman

    Published 2015-09-01
    “…<br />Keywords: Mycobacterium tuberculosis, tuberculosis, pulmonary tuberculosis<br /><br /><br />…”
    Get full text
    Article
  5. 285

    Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion. by Jason D Simmons, R Max Segnitz, Kimberly A Dill-McFarland, Catherine M Stein, Glenna J Peterson, Harriet Mayanja-Kizza, W Henry Boom, Thomas R Hawn

    Published 2023-01-01
    “…Using gene level analytic methods, we previously found distinct monocyte transcriptional responses associated with resistance to Mycobacterium tuberculosis (Mtb) infection defined as persistently negative tuberculin skin test (TST) and interferon gamma release assay (IGRA) reactivity among highly exposed contacts (RSTR phenotype).…”
    Get full text
    Article
  6. 286

    Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review by Alessandro Cassini, Raph L Hamers, Koe Stella Asadinia, Silvia Bertagnolio

    Published 2022-06-01
    “…Introduction To accelerate the response to the public health threat by antimicrobial resistance (AMR), the WHO is developing a Global Research Agenda for AMR in the human health sector that aims to provide a global and transparent assessment of priority knowledge gaps related to critical bacteria—including Mycobacterium tuberculosis—and fungi that inform control and response strategies to tackle AMR by 2030. …”
    Get full text
    Article
  7. 287

    Sequential testing with Xpert MTB/RIF assay for diagnosis of tuberculous meningitis in Maharaj Nakorn Chiang Mai University Hospital by Poramed Winichakoon, Kanokwan Watcharasaksilp, Sunisa Butphet, Kanlaya Wongworapat, Chansom Pantip, Phadungkiat Khamnoi, Khuanchai Supparatpinyo, Parichat Salee

    Published 2025-01-01
    “…The Xpert MTB/RIF assay is a rapid and valuable tool for detecting Mycobacterium tuberculosis in centrifuged CSF specimens. A diagnostic algorithm incorporating the TBM score enhances performance, balancing sensitivity and specificity, and could improve patient outcomes in resource-limited settings.…”
    Get full text
    Article
  8. 288

    Performance of a score to characterise adequate contact among the social network of persons with TB by M.E. Castellanos, S. Zalwango, T.H.T. Quach, R. Kakaire, L. Martínez, M.H. Ebell, K.K. Dobbin, N. Kiwanuka, C.C. Whalen

    Published 2024-12-01
    “…BACKGROUND: Transmission of Mycobacterium tuberculosis requires adequate contact between an infectious case and a susceptible host. …”
    Get full text
    Article
  9. 289

    Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugs by Ririh Jatmi Wikandari, Surati, Siti Nuryani, Sistoyono

    Published 2024-12-01
    “…Tuberculosis (TB) is an airborne infectious disease caused by Mycobacterium tuberculosis. Indonesia ranks third in the number of global TB cases. …”
    Get full text
    Article
  10. 290

    Diagnostic accuracy of cartridge-based nucleic acid amplification test and resistance pattern in new and previously treated tuberculosis cases: A prospective observational study by Ranjit Suva, Gaurang Khadiya, Kinjal D. Rami, Urvashi Modh, Firoz Ghanchi, Yogesh Murugan

    Published 2024-06-01
    “…CBNAAT is a rapid molecular test that detects the genetic material of Mycobacterium tuberculosis (MTB), the bacterium causing TB, in sputum samples. …”
    Get full text
    Article
  11. 291

    Severe Tuberculosis Requiring Intensive Care: A Descriptive Analysis by Raquel Pacheco Duro, Paulo Figueiredo Dias, Alcina Azevedo Ferreira, Sandra Margarida Xerinda, Carlos Lima Alves, António Carlos Sarmento, Lurdes Campos dos Santos

    Published 2017-01-01
    “…The diagnosis of isolated pulmonary TB, a positive smear for acid-fast-bacilli and a positive PCR for Mycobacterium tuberculosis in patients of pulmonary disease, severe sepsis/septic shock, acute renal failure and Multiple Organ Dysfunction Syndrome on admission, the need for mechanical ventilation or vasopressor support, hospital acquired infection, use of adjunctive corticotherapy, smoking, and alcohol abuse were significantly associated with mortality (p<0.05). …”
    Get full text
    Article
  12. 292

    The role of isoniazid dosage and NAT2 gene polymorphism in the treatment of tuberculous meningitis by Yi Jian, Yuhang Bao, Fashuang Yang, Mei Zhu

    Published 2025-01-01
    “…BackgroundTuberculous meningitis (TBM) is a non-purulent inflammatory condition affecting the meninges and spinal membranes, caused by Mycobacterium tuberculosis (MTB) infection. This study seeks to explore the impact of varying INH dosages and NAT2 gene polymorphisms on TBM treatment, contributing new insights to improve clinical management and patient prognosis.MethodsPatients with TBM hospitalized between July 2020 and December 2022 were categorized into two groups based on INH dosage: the standard-dose group (300 mg/day) and the high-dose group (600 mg/day). …”
    Get full text
    Article
  13. 293

    Interferon (IFN)-gamma (γ) inducible protein 10 (IP-10) in the diagnosis of latent and active tuberculosis in Bacille Calmette Guerin (BCG)-vaccinated pediatric population. by Magdalena Druszczynska, Michał Seweryn, Sebastian Wawrocki, Anna Pankowska, Anastasiia Kulbachko, Magdalena Jurczak, Magdalena Kowalewska-Pietrzak

    Published 2025-01-01
    “…Furthermore, detecting cases of latent Mycobacterium tuberculosis (M.tb) infection (LTBI) that have a high risk of progressing to active TB disease remains a significant diagnostic hurdle.…”
    Get full text
    Article
  14. 294

    Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB by E.T. Abbew, R. Laryea, F. Sorvor, Y.A. Poku, N. Lorent, D. Obiri-Yeboah, L. Lynen, L. Rigouts

    Published 2024-07-01
    “…The MPT64 assay was performed on positive cultures to distinguish between Mycobacterium tuberculosis complex MTBc and NTM. NTM isolates were re-cultured for species identification using GenoType® Mycobacterium CM/AS line-probe assay, polymerase chain reaction, and Sanger sequencing targeting 16S rRNA and rpoB genes. …”
    Get full text
    Article
  15. 295

    Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case Report by Bhaveshkumar Manilal Patel, Mugdha Manaji Kadam, Arti Dhawal Shah, Chirag Chakravarti, Virenkumar Jayendrakumar Patel

    Published 2025-01-01
    “…These drugs are essential for the treatment of TB, a contagious bacterial infection caused by Mycobacterium tuberculosis. However, antitubercular drugs can lead to various skin reactions, which may range from mild to severe. …”
    Get full text
    Article
  16. 296

    Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis by Yone Vila Nova Cavalcanti, Maria Carolina Accioly Brelaz, Juliana Kelle de Andrade Lemoine Neves, José Candido Ferraz, Valéria Rêgo Alves Pereira

    Published 2012-01-01
    “…Host immune response against Mycobacterium tuberculosis is mediated by cellular immunity, in which cytokines and Th1 cells play a critical role. …”
    Get full text
    Article
  17. 297

    Development of a Highly Biocompatible Antituberculosis Nanodelivery Formulation Based on Para-Aminosalicylic Acid—Zinc Layered Hydroxide Nanocomposites by Bullo Saifullah, Palanisamy Arulselvan, Mohamed Ezzat El Zowalaty, Sharida Fakurazi, Thomas J. Webster, Benjamin Geilich, Mohd Zobir Hussein

    Published 2014-01-01
    “…The developed formulation has a fourfold higher efficacy of PAS against mycobacterium tuberculosis with a minimum inhibitory concentration (MIC) found to be at 1.40 μg/mL compared to the free drug PAS with a MIC of 5.0 μg/mL. …”
    Get full text
    Article
  18. 298

    Synthesis and Antitubercular Activity of Heteroaromatic Isonicotinoyl and 7-Chloro-4-Quinolinyl Hydrazone Derivatives by Marcelle de L. Ferreira, Raoni S.B. Gonçalves, Laura N. de F. Cardoso, Carlos R. Kaiser, Andre L.P. Candéa, Maria das Graças M. de O. Henriques, Maria C.S. Lourenço, Flávio A.F.M. Bezerra, Marcus V. N. de Souza

    Published 2010-01-01
    “…Two series of N’(E)-heteroaromatic-isonicotinohydrazide derivatives (3a-f and 4a-b) and 1-(7-chloroquinolin-4-yl)-2-[(heteroaromatic)methylene]hydrazone derivatives (5a-f and 6a-b) have been synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv. Several compounds were noncytotoxic and exhibited significant minimum inhibitory concentration (MIC) activity (3.12, 2.50, 1.25, or 0.60 μg/mL), which can be compared to that of the first-line drugs ethambutol (3.12 μg/mL) and rifampicin (2.0 μg/ml). …”
    Get full text
    Article
  19. 299

    Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control... by Fantahun Admassu, Ermias Abera, Addisalem Gizachew, Tagesse Sedoro, Taye Gari

    Published 2023-01-01
    “…Cases were all patients with TB with culture proven or line probe assay confirmed Mycobacterium tuberculosis resistant to at least both isoniazid and rifampicin and registered on second-line TB treatment. …”
    Get full text
    Article
  20. 300

    Dissociação clinicorradiológica em lactente com tuberculose pulmonar: relato de caso by Débora Elisabeth Sales Vieira, Rafael José Souza Filho, Rebecca da Silva Sales Vieira, Ana Carolina Gonçalves Galeano Arco, Juliènne Martins Araújo, Clarissa Netto dos Reys Laia Franco Prillwitz, Christiane Mello Schmidt, Claudete Araújo Cardoso

    Published 2024-09-01
    “…Pulmonary tuberculosis (TB) is a preventable treatable and infectious disease caused by Mycobacterium tuberculosis (Mtb). The infection occurs through the inhalation of droplets expelled by an individual with the active disease. …”
    Get full text
    Article